FDA: Counterfeit Ozempic Linked to Hospitalizations

Published on November 8, 2023

The U.S. Food and Drug Administration has received at least three reports of people being hospitalized after taking counterfeit versions of the wildly popular weight-loss drugs known as semaglutides. At least one of these reports includes mention of a counterfeit version of…

Read Full Article (External Site)